Middle East and Africa Multimodal Image Fusion Software Market is expected to reach US$ 29.16 million by 2028

Published Date: 04 Mar 2022

Hospitals Segment to Dominate MEA Multimodal Image Fusion Software Market during 2021–2028

According to The Insight Partners market research study on “MEA Multimodal Image Fusion Software Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and Application” is expected to reach US$ 29.16 million by 2028 from US$ 18.89 million in 2021. The market is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report provides trends prevailing in the MEA multimodal image fusion software market along with the drivers and restraints pertaining to the market growth. Rising prevalence of chronic and acute diseases is the major factor driving the growth of the MEA multimodal image fusion software market. However, issues associated with the high cost of associated diagnostics equipment hinder the growth of MEA multimodal image fusion software market.  

The MEA multimodal image fusion software market is segmented into type, application and country. In terms of type, the multimodal image fusion software market is bifurcated into preclinical multimodal imaging and clinical multimodal imaging. The clinical multimodal imaging segment dominated the market in 2020 and preclinical multimodal imaging segment is expected to be the fastest growing during the forecast period. Based on application, the multimodal image fusion software market is categorized into hospitals, diagnostic centers, and academic and research institutes. The hospitals segment dominated the market in 2020 and diagnostic centers segment is expected to be the fastest growing during the forecast period. Based on country, MEA multimodal image fusion software market is classified into UAE, Saudi Arabia, South Africa, and Rest of APAC.

Saudi Arabia, the UAE, Egypt, Morocco, and Kuwait are the main countries facing the impact of COVID-19 in the Middle East and African region. It is becoming clear with the COVID-19 pandemic spreading through the above-mentioned countries have huge challenging impacts across all major industries present in the region. However, the healthcare sector in these countries has not experienced any major challenge, as all services other than COVID-19 treatment were also equally operational. The countries across Middle East and Africa such as UAE have experienced high investments in healthcare technologies over the past years, which also continued during the pandemic. Thus, the COVID-19 pandemic has no direct impact on the multimodal image fusion software market in the region.

Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; and PerkinElmer Inc. are among the leading companies in the MEA multimodal image fusion software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2018, Bruker Corporation had launched ParaVision 360 preclinical imaging software. It is the most advanced research-grade software for preclinical MRI and had also been extended to nuclear molecular imaging.


MEA Multimodal Image Fusion Software Market, By Country, 2020 and 2028 (%) 

Report : Middle East and Africa Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com 

Download Free PDF Brochure